Mesothelioma Survival: 18-Year Survivor's Story

When Tamron Little was 21 years old and pregnant, an ultrasound revealed something unexpected. What doctors initially thought was a fibroid tumor turned out to be peritoneal mesothelioma, a rare cancer affecting the lining of the abdomen. She was given 18 months to live. Eighteen years later, she is cancer-free, a mother of four, and a patient advocate whose story challenges the bleakest assumptions about this disease.

Her account, shared with CURE Today, offers one of the most detailed glimpses into what long-term mesothelioma survivorship actually looks like.

A Diagnosis No One Expected

Peritoneal mesothelioma, which affects the abdominal lining, accounts for approximately 300 new diagnoses in the US each year. It is rarer than the pleural form but has significantly better survival outcomes when treated with cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC).

Little’s case was complicated by her pregnancy. She had to wait until five months after giving birth to undergo a 12-hour HIPEC surgery, a procedure that removes visible tumors from the abdominal cavity and then bathes the area in heated chemotherapy to kill remaining cancer cells.

The Treatment That Changed Her Odds

HIPEC combined with cytoreductive surgery has transformed outcomes for peritoneal mesothelioma. Five-year survival rates at specialized centers range from 65% to 80%, a stark contrast to the 10% five-year survival rate for pleural mesothelioma. Women with peritoneal mesothelioma show nearly triple the five-year survival rate compared to men, according to published studies.

Little’s surgery was successful, but the treatment came with lasting consequences. She developed chronic kidney disease from the heated chemotherapy, a known long-term complication of HIPEC. Her experience illustrates a reality that survival statistics alone do not capture: long-term survivorship often means living with the permanent effects of aggressive treatment.

What 18 Years of Survival Looks Like

Long-term survival does not mean the disease disappears. For Little, the years since treatment have involved ongoing monitoring, periodic scans, and the constant possibility of recurrence. She has also navigated parenthood while managing a chronic health condition, ultimately having three more children after her diagnosis.

Her experience over 18 years has included:

• Multiple follow-up surgeries and monitoring scans
• Permanent changes in digestion and daily function from HIPEC
• Chronic kidney disease requiring ongoing management
• Raising four children while living with a cancer diagnosis
• Becoming a patient advocate to help others facing the same journey

“Survivors need to share their stories and make their voices heard,” Little has said, describing her transition from patient to advocate. She began publicly sharing her experience in 2018, more than a decade after her diagnosis.

Why Her Story Matters

Mesothelioma survival stories challenge the narrative that this cancer is always fatal within months. While aggressive disease still claims many patients quickly, advances in treatment, particularly HIPEC for peritoneal mesothelioma, have created a growing population of long-term survivors whose experiences are not reflected in older statistics.

These stories matter because they demonstrate the importance of seeking evaluation at specialized mesothelioma centers, where access to HIPEC, clinical trials, and multidisciplinary care can significantly affect outcomes. Little’s case also highlights how a second opinion changed the course of her life, after the initial misdiagnosis of a fibroid tumor.